Jafar Golzarian, SIR 2015’s programme chair, discusses some of the most exciting sessions from the Society of Interventional Radiology’s (SIR’s) upcoming Annual Scientific Meeting (28 February–5 March 2015, Atlanta, USA) for Interventional News.
Hansen has announced that an abstract accepted for presentation at the 40th Annual Society of Interventional Radiology (SIR) Meeting (28 February–5 March 2015, Atlanta, USA), has found that the use of the Magellan Robotic System in transarterial chemoembolization (TACE) procedures is feasible, and that remote robotic catheter navigation with Magellan leads to over 80% reduction in radiation dose to the operating physician when compared with a bedside control.
The results were presented at the seventh annual Symposium on Clinical Interventional Oncology (CIO, 31 January–5 February, Hollywood, USA), in collaboration with the International Symposium on Endovascular Therapy (ISET, 31 January–5 February, Hollywood, USA) by Ravi Murthy, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, USA.
Combined data from more than 1,000 patients is being collected to assess the overall survival benefit of adding first-line SIR-Spheres Y-90 resin microspheres treatment to a current chemotherapy regimen for inoperable metastatic colorectal cancer.
Clinical work and data will be presented on Humacyte’s novel bioengineered blood vessel at the 27th International Symposium on Endovascular Therapy (ISET, 31 January–4 February, Hollywood, USA).
The Society of Interventional Radiology Foundation has released a statement announcing that the NIH-sponsored ATTRACT (Acute venous thrombosis: thrombus removal with adjunctive catheter-directed thrombolysis study) has completed accrual of its originally planned cohort of 692 patients.
Bariatric embolization is the first catheter-based procedure that attempts to directly address obesity. The minimally invasive technique is expected to decrease the hormone ghrelin, responsible for appetite, resulting in weight loss. Currently, the only proven long-term procedural solution for substantial weight loss is bariatric surgery, an often extensive operation.
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched a new observational study that will gather data on patients with primary and secondary liver tumours treated with SIR‐Spheres microspheres at specialist hospitals across Europe.
CeloNova BioSciences has announced that it has received an expanded indication (CE mark) in Europe for its Embozene embolic microspheres to include the treatment of benign prostatic hyperplasia.
The results of a web-based survey designed to shed light on the practice of transarterial chemoembolization (TACE) in the UK have shown that there is a wide variation in practice with some centres using conventional TACE (with lipiodol and doxorubicin) and others using, newer drug-eluting beads.
SIR has unveiled a new brand for the society and its research organisation—SIR Foundation—reinforcing its commitment to patient-driven care and highlighting the power and potential of interventional radiology. The new logos for both organisations convey the limitless possibilities of image-guided therapies to solve the toughest medical problems. SIR’s new tagline, “The vision to heal” reflects the innovative, patient-driven care that board-certified interventional radiologists deliver through methods that result in less risk, less pain and shorter recovery time than traditional surgery.
Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue.
Recent advances in tissue engineering have led to an investigational off-the-shelf bioengineered blood vessel for implantation and provide vascular access for dialysis patients. The current standard of care for patients with end-stage renal disease requiring haemodialysis includes surgery to create an arteriovenous fistula, placement of a synthetic polytetrafluoroethylene (PTFE) graft, or a central venous catheter. Research shows that up to 50% of patients fail to adequately mature their fistulae after creation and are not suitable for dialysis within five months after surgical placement. Likewise, PTFE grafts are subject to a range of complications, including thrombosis, outflow vein stenosis, infection and high intervention rates to maintain blood flow. Catheters are known to have high rates of infection, inefficient dialysis and are associated with inducing central vein stenosis and occlusion.
CO2 angiography can decrease both morbidity and mortality for patients, in certain clinical scenarios. For those driven by economics, the cost of 100cc of CO2 is approximately three cents. Its use is limited only by one’s imagination. So why is it not more widely used?
Stentoplasty, or vertebral body stenting, represents the next step in the evolution of cement spinal augmentation where a stent is placed within the vertebral body followed by infusion of cement. Current available systems include the Osseofix system (Alphatec Spine) and the VBS system (Synthes). Uei Pua writes about the future directions of the procedure.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos